Cloud Security : A Review of Recent Threats and Solution Models

The most significant barrier to the wide adoption of cloud services has been attributed to perceived cloud insecurity (Smitha, Anna and Dan, 2012). In an attempt to review this subject, this paper will explore some of the major security threats to the cloud and the security models employed in tackling them. Access control violations, message integrity violations, data leakages, inability to guarantee complete data deletion, code injection, malwares and lack of expertise in cloud technology rank the major threats. The European Union invested €3m in City University London to research into the certification of Cloud security services. This and more recent developments are significant in addressing increasing public concerns regarding the confidentiality, integrity and privacy of data held in cloud environments. Some of the current cloud security models adopted in addressing cloud security threats were – Encryption of all data at storage and during transmission. The Cisco IronPort S-Series web security appliance was among security solutions to solve cloud access control issues. 2-factor Authentication with RSA SecurID and close monitoring appeared to be the most popular solutions to authentication and access control issues in the cloud. Database Active Monitoring, File Active Monitoring, URL Filters and Data Loss Prevention were solutions for detecting and preventing unauthorised data migration into and within clouds. There is yet no guarantee for a complete deletion of data by cloud providers on client requests however; FADE may be a solution (Yang et al., 2012)

Reconsidering the Role of Youth : Generational Differences in Political and Social Attitudes in the Arab World

Publisher PD

MENA in 2014 : Do People Think Their Nation is Secure?

Acknowledgements The Arab Transformations Project is coordinated by the University of Aberdeen (UK) and includes a further 11 partners: Dublin City University (DCU), Dublin, Ireland; Análisis Sociológicos Económicos y Políticos (ASEP), Madrid, Spain; Istituto per gli Studi di Politica Internazionale (ISPI), Milan, Italy; Universität Graz (UNI GRAZ), Graz, Austria; Societatea Pentru Methodologia Sondajelor Concluzia- Prim (Concluzia), Chisinau, Moldova; Centre de Recherche en Économie Appliquée pour le Développement (CREAD), Algiers, Algeria; Egyptian Centre for Public Opinion Research (BASEERA); Cairo, Egypt; Independent Institute for Administration and Civil Society Studies (IIACSS), Amman, Jordan; University of Jordan (JU), Amman, Jordan; MEDA Solutions (MEDAS), Casablanca, Morocco; Association Forum Des Sciences Sociales Appliquées (ASSF); Tunis, Tunisia. The author would also like to acknowledge the World Values Survey, Arab Barometer and AfroBarometer, on whose survey data they draw. We are also grateful to Viola Sanelli and Ilia Xypolia, at the University of Aberdeen, for material they supplied on the history and politics of the regionPublisher PD

Thermal degradation of monoethanolamine and its effect on CO2 capture capacity.

Amine scrubbing is a proven technology in the oil and gas industries. Its use in coal fired power plants is not fully understood and the likelihood of solvent degradation is high. Decreased absorption efficiency, undesirable by-products and the environmental impact of their disposal are the main consequences. In the present study, samples of monoethanolamine were thermally degraded, at 160 °C for between 2 and 8 weeks, and their CO2 removal capacity deterioration was determined. The findings show that thermal degradation at 160 °C for 8 weeks reduced monoethanolamine concentration by 95%, but the remaining solvent still retained 22% of its capacity to remove CO2, probably due to the capacity of some of the degradation products to remove CO2. Therefore, the requirement for monoethanolamine make-up in operational amine scrubbing systems may not be quite as serious as initially believed. A 20% higher MEA loss was determined in the samples with 0.37 initial CO2 loading (mol CO2/mol MEA). 2-Oxazolidone, N-(2-hydroxyethyl)-ethylenediamine and 1-(2-hydroxyethyl)-2-imidazolidinone were identified as the major monoethanolamine degradation products, the latter being indicated as the most stable product with concentrations of up to 17% (v/v). Corrosion (1.95 mm/year) of the stainless steel (type 316) equipment, used during the experiments, was also observed

Development of a parental feeding goal measure: the family mealtime goals questionnaire

It is well established that parents’ feeding practices predict children’s eating behaviors. However, there has been little research into parents’ mealtime goals – their desired outcomes for family mealtimes. These goals, and potential conflicts between them, may be important both in explaining parents’ feeding practices and improving children’s eating behaviors, as health behavior change is more likely to be achieved by programmes and interventions that are aligned with an individual’s goals. The objectives of this study were to develop a reliable and valid measure that captures parental mealtime goals, and to describe parents’ endorsement of these goals. Online questionnaire methods were used to design and test the Family Mealtime Goals Questionnaire with 1,140 parents and carers of at least one child aged from 1 to 16 years. Exploratory qualitative analysis, Principal Components Analysis, Confirmatory Factor Analysis and test-retest analysis (using intraclass correlations) were conducted to establish the psychometric properties of the instrument. An 18-item questionnaire was produced with seven dimensions: stress/conflict avoidance, homemade food, shared family food, family involvement in mealtimes, price, occasional treats, and high/low fat regulation. Some differences were found in the goal structure of parents of children of different ages but stress/conflict avoidance was the most strongly endorsed mealtime goal for all age groups. The Family Mealtime Goals Questionnaire provides a useful measure of parents’ feeding motivations. It will facilitate large-scale research into the relationships between parents' feeding goals and practices and could inform the design of more effective healthy eating interventions that target specific feeding goals

Multiplexed Electrochemical Detection of Yersinia Pestis and Staphylococcal Enterotoxin B using an Antibody Microarray

The CombiMatrix antibody microarray is a versatile, sensitive detection platform based on the generation and transduction of electrochemical signals following antigen binding to surface antibodies. The sensor chip described herein is comprised of microelectrodes coupled to an adjacent bio-friendly matrix coated with antibodies to the biological pathogens Yersinia pestis and Bacillus anthracis, and the bacterial toxin staphylococcal enterotoxin B (SEB). Using this system, we were able to detect SEB and inactivated Y. pestis individually as well as in two-plex assays at concentrations as low as 5 pg/mL and 106 CFU/mL, respectively. We also introduce super avidin-biotin system (SABS) as a viable and effective means to enhance assay signal responses and lower detection limits. Together these technologies represent substantial advances in point-of-care and point-of-use detection applications

Optical Biosensors Based on Semiconductor Nanostructures

The increasing availability of semiconductor-based nanostructures with novel and unique properties has sparked widespread interest in their use in the field of biosensing. The precise control over the size, shape and composition of these nanostructures leads to the accurate control of their physico-chemical properties and overall behavior. Furthermore, modifications can be made to the nanostructures to better suit their integration with biological systems, leading to such interesting properties as enhanced aqueous solubility, biocompatibility or bio-recognition. In the present work, the most significant applications of semiconductor nanostructures in the field of optical biosensing will be reviewed. In particular, the use of quantum dots as fluorescent bioprobes, which is the most widely used application, will be discussed. In addition, the use of some other nanometric structures in the field of biosensing, including porous semiconductors and photonic crystals, will be presented

Effect of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker initiation on organ support-free days in patients hospitalized with COVID-19

IMPORTANCE Overactivation of the renin-angiotensin system (RAS) may contribute to poor clinical outcomes in patients with COVID-19. Objective To determine whether angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) initiation improves outcomes in patients hospitalized for COVID-19. DESIGN, SETTING, AND PARTICIPANTS In an ongoing, adaptive platform randomized clinical trial, 721 critically ill and 58 non–critically ill hospitalized adults were randomized to receive an RAS inhibitor or control between March 16, 2021, and February 25, 2022, at 69 sites in 7 countries (final follow-up on June 1, 2022). INTERVENTIONS Patients were randomized to receive open-label initiation of an ACE inhibitor (n = 257), ARB (n = 248), ARB in combination with DMX-200 (a chemokine receptor-2 inhibitor; n = 10), or no RAS inhibitor (control; n = 264) for up to 10 days. MAIN OUTCOMES AND MEASURES The primary outcome was organ support–free days, a composite of hospital survival and days alive without cardiovascular or respiratory organ support through 21 days. The primary analysis was a bayesian cumulative logistic model. Odds ratios (ORs) greater than 1 represent improved outcomes. RESULTS On February 25, 2022, enrollment was discontinued due to safety concerns. Among 679 critically ill patients with available primary outcome data, the median age was 56 years and 239 participants (35.2%) were women. Median (IQR) organ support–free days among critically ill patients was 10 (–1 to 16) in the ACE inhibitor group (n = 231), 8 (–1 to 17) in the ARB group (n = 217), and 12 (0 to 17) in the control group (n = 231) (median adjusted odds ratios of 0.77 [95% bayesian credible interval, 0.58-1.06] for improvement for ACE inhibitor and 0.76 [95% credible interval, 0.56-1.05] for ARB compared with control). The posterior probabilities that ACE inhibitors and ARBs worsened organ support–free days compared with control were 94.9% and 95.4%, respectively. Hospital survival occurred in 166 of 231 critically ill participants (71.9%) in the ACE inhibitor group, 152 of 217 (70.0%) in the ARB group, and 182 of 231 (78.8%) in the control group (posterior probabilities that ACE inhibitor and ARB worsened hospital survival compared with control were 95.3% and 98.1%, respectively). CONCLUSIONS AND RELEVANCE In this trial, among critically ill adults with COVID-19, initiation of an ACE inhibitor or ARB did not improve, and likely worsened, clinical outcomes. TRIAL REGISTRATION ClinicalTrials.gov Identifier: NCT0273570